Published in Blood on May 01, 1980
Inhibition of human polymorphonuclear leukocyte function by 2-cyclohexene-1-one. A role for glutathione in cell activation. J Clin Invest (1981) 0.94
Oxidation of neutrophil glutathione and protein thiols by myeloperoxidase-derived hypochlorous acid. Biochem J (1997) 0.90
Neutrophil-endothelial cell interaction. Evidence for and mechanisms of the self-protection of bovine microvascular endothelial cells from hydrogen peroxide-induced oxidative stress. J Clin Invest (1986) 0.84
Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest (1975) 6.25
Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin. Biochim Biophys Acta (1970) 3.31
Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes. J Lab Clin Med (1975) 3.24
Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood (1997) 3.19
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol (2007) 2.85
gamma-beta-Thalassaemia studies showing that deletion of the gamma- and delta-genes influences beta-globin gene expression in man. Nature (1980) 2.68
The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature (1988) 2.65
Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood (1995) 2.39
Functional activity of enucleated human polymorphonuclear leukocytes. J Cell Biol (1983) 2.32
Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci U S A (2000) 2.26
Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study. J Lab Clin Med (1974) 2.14
Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood (1991) 2.05
Production of hydrogen peroxide by phagocytizing human granulocytes. J Lab Clin Med (1975) 2.05
Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. II. Relative importance of glycolysis and oxidative phosphorylation on phytohaemagglutinin stimulation. Exp Cell Res (1973) 1.87
Brominating oxidants generated by human eosinophils. Science (1986) 1.86
Actin filament polymerization regulates gliding motility by apicomplexan parasites. Mol Biol Cell (2003) 1.85
Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol (1992) 1.76
Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J Clin Invest (1978) 1.66
Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. Blood (1989) 1.66
Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ (2004) 1.65
Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys (2000) 1.64
The 40-kDa Fc gamma receptor (FcRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis. J Immunol (1989) 1.63
Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency. Blood (1979) 1.60
Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood (1990) 1.59
Purification and cryopreservation of phagocytes from human blood. Methods Enzymol (1986) 1.58
Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J Immunol (2000) 1.57
Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci (1999) 1.57
Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood (1995) 1.55
Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest (1997) 1.51
Interaction between human neutrophils and zymosan particles: the role of opsonins and divalent cations. J Immunol (1981) 1.51
Monitoring of platelet morphology during storage of platelet concentrates. Transfusion (1989) 1.47
Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol (1991) 1.47
Phagocytosing human neutrophils inactivate their own granular enzymes. J Clin Invest (1981) 1.42
Purified protein kinase C phosphorylates a 47-kDa protein in control neutrophil cytoplasts but not in neutrophil cytoplasts from patients with the autosomal form of chronic granulomatous disease. J Biol Chem (1988) 1.39
Phylogeography of the green turtle, Chelonia mydas, in the Southwest Indian Ocean. Mol Ecol (2007) 1.39
Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD18, ELAM-1, and VLA-4. Blood (1991) 1.37
Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J Immunol (1990) 1.37
Characterization and quantification of the peroxidase in human monocytes. Biochim Biophys Acta (1978) 1.35
A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease. Eur J Hum Genet (2000) 1.35
The molecular basis of chronic granulomatous disease. Springer Semin Immunopathol (1998) 1.33
Apoptosis of neutrophils. Acta Haematol (2004) 1.32
CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J Cell Biol (1992) 1.31
Binding characteristics of dimeric IgG subclass complexes to human neutrophils. J Immunol (1989) 1.28
Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest (1990) 1.27
Kinetics and mechanism of the bactericidal action of human neutrophils against Escherichia coli. Blood (1984) 1.25
Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol (2003) 1.25
1-O-hexadecyl-2-Q-methylglycerol, a novel inhibitor of protein kinase C, inhibits the respiratory burst in human neutrophils. J Biol Chem (1989) 1.24
Purification and partial characterization of the b-type cytochrome from human polymorphonuclear leukocytes. J Biol Chem (1985) 1.23
Extracellular proton release by stimulated neutrophils. J Clin Invest (1981) 1.23
Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). Blood (1990) 1.22
Granulocytes without degranulation: neutrophil function in granule-depleted cytoplasts. Proc Natl Acad Sci U S A (1983) 1.22
Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood (1994) 1.20
Defects in the oxidative killing of microorganisms by phagocytic leukocytes. Ciba Found Symp (1979) 1.20
Hematologically important mutations: X-linked chronic granulomatous disease (second update). Blood Cells Mol Dis (2001) 1.19
Neutrophil activation in sickle cell disease. J Leukoc Biol (1999) 1.19
A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest (1994) 1.18
Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Blood (1991) 1.17
Effect of cytochalasin B on the oxidative metabolism of human peripheral blood granulocytes. Biochem Biophys Res Commun (1976) 1.16
Defective initiation of the metabolic stimulation in phagocytizing granulocytes: a new congenital defect. J Lab Clin Med (1976) 1.15
Cytochrome b, flavins, and ubiquinone-50 in enucleated human neutrophils (polymorphonuclear leukocyte cytoplasts). J Biol Chem (1984) 1.14
A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils. J Clin Invest (1989) 1.14
Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization. J Clin Invest (1985) 1.14
Ficoll-isopaque gradients for the determination of density distributions of human blood lymphocytes and other reticulo-endothelial cells. Exp Cell Res (1974) 1.14
Cytotoxic activity of human monocytes towards sensitized red cells is not dependent on the generation of reactive oxygen species. Blood (1979) 1.13
Beta1 integrin activation on human neutrophils promotes beta2 integrin-mediated adhesion to fibronectin. Eur J Immunol (2001) 1.12
Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. Clin Exp Immunol (1987) 1.12
Interactions between the cytosolic components p47phox and p67phox of the human neutrophil NADPH oxidase that are not required for activation in the cell-free system. J Biol Chem (1995) 1.10
Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways. Eur J Immunol (1991) 1.10
Assembly and activation of the NADPH:O2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate. J Biol Chem (1990) 1.10
Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J Neuroimmunol (1998) 1.09
Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b558 and the adhesion molecule CD11b/CD18. Blood (1993) 1.09
Metabolic comparison between basophils and other leukocytes from human blood. J Immunol (1986) 1.09
Immunologic studies with LFA-1- and Mo1-deficient lymphocytes from a patient with recurrent bacterial infections. J Immunol (1985) 1.09
Location of the epitope for 7D5, a monoclonal antibody raised against human flavocytochrome b558, to the extracellular peptide portion of primate gp91phox. Microbiol Immunol (2001) 1.08
Complementation in monocyte hybrids revealing genetic heterogeneity in chronic granulomatous disease. Nature (1984) 1.08
Large-scale purification and cryopreservation of human monocytes. J Immunol Methods (1981) 1.08
[Molecular genetic studies in alpha-thalassemia]. Ned Tijdschr Geneeskd (1992) 1.07
Splice site mutations are a common cause of X-linked chronic granulomatous disease. Blood (1992) 1.07
Responsibility after gastrectomy. Lancet (1965) 1.07
Divergent effects of tumor necrosis factor alpha on apoptosis of human neutrophils. J Leukoc Biol (2001) 1.06
The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum (1998) 1.05
Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr (1995) 1.05
Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol (2000) 1.04
156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med (1994) 1.04
Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter-structure in the aggregation response of human neutrophils. Eur J Immunol (1990) 1.03
The plasma concentration of soluble Fc-gamma RIII is related to production of neutrophils. Br J Haematol (1994) 1.03
Purification of eosinophils from normal human blood, preparation of eosinoplasts and characterization of their functional response to various stimuli. Immunology (1987) 1.03
Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med (2008) 1.02